| ALT | Alanine aminotransferase |
| AST | Aspartate aminotransferase |
| CAP | Controlled attenuation parameter |
| CKD | Chronic kidney disease |
| FIB-4 | Fibrosis-4 Index |
| LPS | Lipopolysaccharide |
| MAFLD | Metabolic dysfunction-associated fatty liver disease |
| MASLD | Metabolic dysfunction-associated steatotic liver disease |
| MASH | Metabolic dysfunction-associated steatohepatitis |
| MetALD | Metabolic alcohol-related liver disease |
| MRE | Magnetic resonance elastography |
| MRI-PDFF | Magnetic resonance imaging-proton density fat fraction |
| NAFLD | Non-alcoholic fatty liver disease |
| NASH | Non-alcoholic steatohepatitis |
| NFS | NAFLD Fibrosis Score |
| T2DM | Type 2 diabetes mellitus |
| VCTE | Vibration-controlled transient elastography |
| TNF-α | Tumor necrosis factor-alpha |
| IL-6 | Interleukin-6 |
| TLR4/NF-κB | Toll-like receptor 4/nuclear factor-kappa B |
| AMPK | AMP-activated protein kinase |
| ROS | Reactive oxygen species |
| STK39 | Serine-threonine kinase 39 |